Sökning: "18F-FDG PET CT"
Visar resultat 1 - 5 av 15 avhandlingar innehållade orden 18F-FDG PET CT.
1. PET/CT in oncology : Patient experience, image quality and the value of information
Sammanfattning : The overall aim was to investigate patients’ experiences with a PET/CT examination, satisfaction with care provided in connection to the examination and whether web-based information can improve satisfaction with care and image quality, compared to standard care. An additional aim was to explore how satisfaction with care and image quality is associated with health-related quality of life (HRQoL) and perceived stress. LÄS MER
2. PET/CT with 18F-FDG and 68Ga-DOTATOC in pulmonary carcinoid imaging
Sammanfattning : Background: PET/CT, positron emission tomography combined with computed tomography, with 18F-FDG (2-deoxy-2-[18F]fluoro-D-glucose) is well established in oncological imaging. Pulmonary carcinoid tumours may have metabolic activity, making them available for PET/CT imaging with 18F-FDG. LÄS MER
3. Aortic valve imaging - Towards new standards in prosthetic valve endocarditis
Sammanfattning : Background: Aortic prosthetic valve endocarditis (PVE) is a disease with high mortality, and diagnosis is difficult. Transesophageal echocardiography (TEE) has been the mainstay imaging modality in the diagnostic workup, but TEE has diagnostic shortcomings. Thus, new imaging methods might improve the diagnostic workup of PVE. LÄS MER
4. Translational PET imaging of inflammation
Sammanfattning : Inflammation is our body’s sophisticated defense mechanism against invading pathogens, traumas, and tumors. Repeatable and non-invasive monitoring of inflammation process would open opportunities to improve our knowledge of several diseases and enable assessment of personalized treatments. LÄS MER
5. Imaging Islets of Langerhans by Positron Emission Tomography : Quantification of Beta-Cell Mass in the Native Pancreas and the Islet Graft
Sammanfattning : Type 1 and 2 Diabetes Mellitus are a growing health problem throughout the world. There is an increasing need for methodologies, which are both reliable and non-invasive to measure the amount of insulin-producing tissue (Beta-cell mass, or BCM), as well as rapidly quantify changes in the BCM due to the onset of disease, beta-cell replacement therapy, or other treatments. LÄS MER